Crédit Industriel et Commercial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Crédit Industriel et Commercial’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-162,062	Closed	-$21.4M	–	442
2025 Q1	$21.4M	Buy	+162,062	New	+$20.2M	2.27%	5

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Crédit Industriel et Commercial's ITCI Position: Q2 2025 in Review

Crédit Industriel et Commercial sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 162,062 shares — an estimated $21.4M sold.

Crédit Industriel et Commercial first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $21.4M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Crédit Industriel et Commercial reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 162,062 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $21.4M.
Crédit Industriel et Commercial first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Intra-Cellular Therapies Inc. position peaked at $21.4M in Q1 2025.
3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2025, filed 28 Jul 2025.